title: Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival.
abstract: OBJECTIVE
  To determine whether in vitro radiosensitivity parameters are predictive of treatment outcome.
  
  
  METHODS
  Biopsies were obtained from patients with head and neck cancers (57) and cervical carcinomas (20) and in vitro radiosensitivity parameters were obtained using the CAM plate assay.
  
  
  RESULTS
  In most cases (75%) patients were treated with radiation alone. The median follow up was 461 days. When the whole group of head and neck cancers and cervical carcinomas was considered, patients with a SF2 value below 0.36 had a higher 2-year local control rate (93% versus 68%) and a higher 2-year survival rate (71% vs. 62%) than those with SF2 values above that threshold, but differences were not significant. These trends persisted when head and neck cancers were considered alone with a higher local control rate (86% vs. 67%) and a higher survival rate (75% vs. 52.5%) obtained for patients with a SF2 value below 0.36. When the alpha value was evaluated for the whole group of patients a significantly higher local control rate (80.5% vs. 40.5%) and overall survival rate (71% versus 37.5%) at 2 years were obtained for patients with alpha values above 0.07 Gy-1. When only the group of head and neck cancers was considered, local control rate was significantly higher (79% vs. 33%) but overall survival rate (65.5% vs. 33%) was not significantly higher for alpha values above 0.07 Gy-1.
  
  
  CONCLUSIONS
  These results are encouraging but need to be confirmed with a larger number of patients with a longer follow-up.
authors.affiliation: Department of Radiotherapy, Unité Inserm 247, Hôpital Pitié Salpétrière, Paris, France.
authors.forename: T
authors.initials: T
authors.lastname: Girinsky
authors.forename: R
authors.initials: R
authors.lastname: Lubin
authors.forename: J P
authors.initials: JP
authors.lastname: Pignon
authors.forename: N
authors.initials: N
authors.lastname: Chavaudra
authors.forename: J
authors.initials: J
authors.lastname: Gazeau
authors.forename: B
authors.initials: B
authors.lastname: Dubray
authors.forename: J M
authors.initials: JM
authors.lastname: Cosset
authors.forename: G
authors.initials: G
authors.lastname: Socie
authors.forename: B
authors.initials: B
authors.lastname: Fertil
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000532:radiotherapy*; D005260:Female; D005500:Follow-Up Studies; D005602:France / Q000453:epidemiology; D006258:Head and Neck Neoplasms / Q000453:epidemiology / Q000532:radiotherapy*; D006801:Humans; D066298:In Vitro Techniques; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology*; D011237:Predictive Value of Tests; D011836:Radiation Tolerance; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000532:radiotherapy*